UK Scientists Eye Soy-Based Drug to Combat Cancer
(London, Reuters Health, 9/27/04)

Although studies indicate that consuming a soy-rich diet long-term may lower the risk of breast cancer, researchers have had difficulty getting the maximum effect from isoflavones, the soybean components thought to create this benefit. The problem is that the body quickly metabolizes the isoflavones. Dr Karen James of the University of Portsmouth in England, and team, having already shown that high doses of soy compounds can reduce cancer cell growth, are now trying to develop ways to make these compounds stay in the body long enough to effectively combat the cancer.